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The VPS4 component of the ESCRT 
machinery plays an essential role 
in HPV infectious entry and capsid 
disassembly
Justyna Broniarczyk1,2, David Pim1, Paola Massimi1, Martina Bergant3, Anna Goździcka-Józefiak2, 
Colin Crump4 & Lawrence Banks1
Human Papillomavirus (HPV) infection involves multiple steps, from cell attachment, through endocytic 
trafficking towards the trans-Golgi network, and, ultimately, the entry into the nucleus during mitosis. 
An essential viral protein in infectious entry is the minor capsid protein L2, which engages different 
components of the endocytic sorting machinery during this process. The ESCRT machinery is one such 
component that seems to play an important role in the early stages of infection. Here we have analysed 
the role of specific ESCRT components in HPV infection, and we find an essential role for VPS4. Loss 
of VPS4 blocks infection with multiple PV types, suggesting an evolutionarily conserved critical step 
in infectious entry. Intriguingly, both L1 and L2 can interact with VPS4, and appear to be in complex 
with VPS4 during the early stages of virus infection. By using cell lines stably expressing a dominant-
negative mutant form of VPS4, we also show that loss of VPS4 ATPase activity results in a marked delay 
in capsid uncoating, resulting in a defect in the endocytic transport of incoming PsVs. These results 
demonstrate that the ESCRT machinery, and in particular VPS4, plays a critical role in the early stages 
of PV infection.
Human Papillomaviruses (HPVs) are the causative agents of a number of prevalent human cancers, with cervical 
cancer being the most important. Over 200 different HPV types have been described, the vast majority of which 
cause only benign lesions1,2. However, a small subset of 12 HPV types have been defined as cancer-causing in the 
cervix3. A critical feature of the HPV life cycle is its intimate link to the differentiation of the infected epithelium. 
These viruses are believed to gain entry into the basal keratinocytes through microtraumas in the skin. Then as 
these basal cells divide and begin terminal differentiation, there is coordinate expression of the different viral 
gene products, ultimately resulting in the production of new infectious viral particles4. Essential players in this 
whole process are the E6 and E7 oncoproteins, which create an environment favourable for viral DNA replication 
within the mid-epithelial layers, where under normal circumstances DNA replication would not be possible5. In 
rare cases this infection cycle is perturbed and changes occur, which can ultimately give rise to the development 
of a cancer6.
The HPV capsid consists of two viral proteins, the major component L1, and the minor component L27. 
Whilst L1 plays an essential role in maintaining the structural integrity of the capsid, the L2 protein appears to 
play a major role in ensuring that the incoming viral genome is trafficked correctly to the nucleus, where viral 
gene expression can initiate8. Infection of the target keratinocyte by HPV appears to be a highly complex process. 
Initial attachment to the basement membrane is believed to occur through association with heparan sulphate 
proteoglycans9,10 and, following a conformational change to the viral capsid, which allows furin cleavage of the L2 
N-terminus, the virus binds to an as yet unidentified receptor on the target cell8,11. The virus is then endocytosed 
by a rather complex and somewhat controversial process12 and, then following endocytic transport and acidifi-
cation, there is progressive capsid uncoating. Finally the L1 and L2 proteins are separated through the action of 
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cyclophilins13, resulting in L1 degradation in the lysosomal compartment14,15. The L2 protein is believed to be 
partially exposed to the cytosol relatively early during the infectious process16,17 and then, L2 recruits components 
of the endocytic sorting machinery, including the retromer, Sorting Nexin 17 (SNX17) and SNX2718–21 which 
together support the transport of the L2-DNA complex to the trans Golgi network22. During mitosis there is 
membrane dissolution and nuclear envelope breakdown, which allows the L2-DNA complex to enter the nucleus 
and initiate viral gene expression at PML oncogenic domains23–26.
Whilst many of the steps in virus entry are beginning to be characterized, there are still major questions about 
the roles of specific stages of endosomal maturation, and in particular that of the formation of multi-vesicular 
bodies (MVBs) and the associated components of the endosomal sorting complex required for transport 
(ESCRT) complex that are required for MVB formation27–29. Analysis of the location of incoming HPV capsids 
had suggested their presence within MVBs12, and studies had also shown a potential requirement for the ESCRT 
component TSG101 for efficient virus entry30. More recently, the ESCRT associated adaptor protein ALIX, was 
also shown to be required for intracellular trafficking of incoming HPVs and subsequent capsid disassembly31. 
The ESCRT machinery is highly complex, involving multiple steps and many different cellular proteins. The 
pathway is broadly defined as comprising four complexes, ESCRT0, I, II, III, with different cellular proteins being 
representative of each stage32. For example TSG101 is part of the ESCRTI complex and HRS defines ESCRT0. The 
VPS4 protein, which has two isoforms, VPS4A and VPS4B, belongs to the family of AAA-ATPAses, which like 
ALIX, are considered to be ESCRT accessory proteins recruited from the cytosol. Through its ATPase activity, 
VPS4 plays an important role in the recycling of the ESCRTIII components and the maintenance of MVBs33,34. In 
order to gain more insight into the potential role of the ESCRT machinery and MVB formation in the HPV entry 
pathway we investigated the potential requirements for HRS and VPS4 for HPV infection. Here we demonstrate 
a critical requirement for the VPS4 ATPase, without which there are major defects in HPV infectious entry. This 
appears to be mediated through a defect in capsid uncoating, resulting in a block to the normal trafficking of L1 
and L2.
Materials and Methods
Cell lines and transfections. HaCaT, HEK293 and HEK293TT35 were maintained in DMEM supple-
mented with 10% fetal bovine serum, penicillin-streptomycin (100 U/ml) and glutamine (300 mg/ml). Ecdysone 
responsive HEK293 cells expressing inducible GFP tagged VPS4 wild type and VPS4EQ mutant were maintained 
in 400 ug/ml Zeocin and 800 ug/ml G418 and VPS4 expression induced by treating with 1 uM ponA (Ponasterone 
A, Invitrogen) for 24 h as described previously36. For transient siRNA experiments the cells were transfected using 
Lipofectamine RNAiMAX (Invitrogen) with siRNAs against TSG101, VPS4A, VPS4B, HRS (ON-TARGETplus 
SMARTpools, Dharmacon) or non-targeting siRNA (scrambled siRNA) as a control. For HEK293 cell transfec-
tions calcium phosphate precipitation was used37.
For HEK293 cell transfections calcium phosphate precipitation was used37.
Plasmids. The plasmids expressing the HPV-16 L1 and HPV-16 L2 GST fusion proteins have been described 
previously20. GFP tagged VPS4A and DsRed tagged VPS4B have been described previously38 and were kindly 
provided by Wesley Sundquist. His-tagged VPS4B expression plasmids were provided by Wesley Sundquist and 
John McCullough. HRS-pEGFP-C plasmid was kindly provided by Clarisse Berlioz-Torrent and has also been 
described previously39.
Antibodies. The following primary antibodies were used: mouse anti-TSG101 (C2, Santa Cruz 
Biotechnology), mouse anti-VPS4A and anti-VPS4B (A-11, Santa Cruz Biotechnology, which recognizes both 
isoforms), rabbit anti-HRS (C-7, Santa Cruz Biotechnology), rabbit anti-GFP (FL, Santa Cruz Biotechnology), 
mouse anti-HPV-16 L1 (CAMVIR-1, Santa Cruz Biotechnology. Mouse anti-16 L2 (16.D4 64-81) were kindly 
provided by Martin Müller while the mouse anti 16L1 33L1-7 antibody was kindly provided by Martin Sapp. 
Secondary antibodies conjugated to horseradish peroxidase (HRP, DAKO) or rhodamine (Molecular Probes) 
were used as indicated in the text.
PsVs production. PsVs containing a luciferase reporter plasmid were generated in 293TT cells as described 
previously35. Purity and capsid protein content were determined by SDS PAGE and Coomassie Brilliant blue 
staining while amounts of encapsidated DNA was analysed using Real Time PCR and the copy number was quan-
tified using a standard curve of reporter plasmid DNA.
Infectivity Assays. HaCaT cells were seeded in 12-well plates at a density of 0.3 × 105 cells/well. 72 h after 
siRNA transfection, cells were exposed to 100 vge/cell of luciferase reporter positive PsVs. Infection was moni-
tored 48 h later by luminometric analysis of firefly luciferase activity using the Luciferase Assay System (Promega). 
For each PsV, infection with scrambled siRNA was normalized to 100%, which was then used to calculate the per-
centage reduction following transfection of the cells with the appropriate siRNA.
Ecdysone responsive HEK293 cells expressing inducible VPS4 were seeded in 12-well plates at a density of 
0.75 × 105 cells/well. 1μ M ponA was then added and after 24 h the cells were infected with 100 vge/cell of lucif-
erase reporter positive PsVs. Infection was monitored after 24 h by luminometric analysis of luciferase activity. 
Infection was normalized to 100% in induced cells in order to calculate the reduction in infection efficiency upon 
VPS4 induction. Throughout equal amounts of total cell protein extract were used in the luciferase measurements.
GST pull-down assays. GST-tagged fusion proteins were expressed and purified as described previously40. 
HEK293 cells were transfected with VPS4A tagged GFP, VPS4B tagged DsRED and GFP tagged HRS expression 
plasmids and after 24 h cells were harvested and lysed in RIPA buffer. The extracts were clarified by centrifugation 
and then incubated with the GST fusion proteins for 2 h at room temperature. After extensive washing the bound 
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proteins were analysed by SDS PAGE and western blotting. Direct protein-protein interactions were performed 
using purified His-tagged wild type VPS4B and mutant His-VPS4B 95-444 E235Q were purified on nickel agarose 
and then eluted in 10 mM Tris pH 8.0, 300 mM NaCl, 100 mM Sodium phosphate pH 8.0 and 200 mM imidazole. 
This was then added to GST alone, GST 16 L1 or GST 16 L2 bound to glutathione agarose beads and incubated for 
2 h at room temperature. After washing with PBS containing 1% Triton X-100, the bound proteins were eluted by 
boiling in SDS PAGE sample buffer and analysed by western blotting.
Immnunoprecipitation. HaCaT cells were seeded on 10 cm dishes at a density of 1 × 106. The following day 
the cells were infected with 5 × 108 vge PsVs per dish and kept at 4 °C for 1 h. Cells were then washed and returned 
to 37 °C and then harvested in RIPA at the time points indicated. Extracts were incubated with appropriate anti-
bodies at 4 °C overnight and then incubated with protein A-conjugated sepharose beads for 1 h at room tempera-
ture. Co-immunoprecipitating L1 and L2 proteins were then detected by western blotting.
For assays in the VPS4 expressing HEK293 cells, the cells were seeded on 10 cm dishes that were pre-treated 
with 0.01% Poly-L-lysine (Sigma). The next day VPS4 expression was induced with 1 μ M PonA for 24 h and 
then infected with 5 × 108 vge HPV-16 PsVs per dish. Cells were harvested in RIPA buffer at different time 
post-infection. VPS4 was immunoprecipitated using rabbit anti-GFP antibody at 4 °C overnight and then incu-
bated with protein A-conjugated sepharose beads for 1 h at room temperature. Co-immunoprecipitating L1 and 
L2 proteins were then detected by western blotting.
Protein stability. The inducible expressing VPS4 expressing HEK293 cells were grown overnight on 0.01% 
Poly-L-lysine conjugated 6 well dishes. Cells were infected with PsVs and after 1 h at 4 °C the cells were imme-
diately lysed in SDS sample buffer to monitor total input virus. Another set were then treated with trypsin for 
15 mins and then immediately lysed in SDS sample buffer to detect amount of virus internalized during the first 
hour of incubation. The remaining cells were then incubated at 37 °C for 24 h and then treated with trypsin for 
15 mins to remove any non-internalised virus. The cells were then extracted in SDS sample buffer and the levels 
of L1 and L2 detected by western blotting.
Immunofluorescence. The inducible expressing VPS4 HEK293 cells were grown on 0.01% Poly-L-lysine 
coverslips. VPS4 induction was done by treatment with 1 uM PonA for 24 h and then infected with HPV-16 PsVs 
at 500 vge/cell. 7 h post-infection the cells were fixed in 3.7% paraformaldehyde for 15 min and then stained for 
total L1 using mouse anti L1 antibody (CAMVIR-1) or the uncoating specific anti L1 antibody 33L1-7, followed 
by rhodamine-conjugated rabbit anti-mouse secondary antibody. Slides were visualized using a Zeiss Axiovert 
100 M microscope attached to a LSM 510 confocal unit. For quantification, the relative amount of total L1 positive 
cells and 33L1-7 positive cells were determined based on the total number of cells in each assay where 100 VPS4 
positive cells were analysed in each experiment.
Statistics. All experiments were performed at least three times. Statistical significance was calculated using 
the GraphPad prism 6 software. Two-way Anova test for the ESCRT siRNA experiments and the unpaired t-test 
for the assays in the VPS4 stable cell lines were used.
Results
A subset of ESCRT components is required for HPV infectious entry. Previous studies had shown 
that the ESCRT component TSG101 and ESCRT-associated ALIX were required for infectious entry of HPV-1630,31. 
We were interested first in investigating whether the ESCRT machinery was required for infection with other 
papillomavirus (PV) types and, further, how the ESCRT machinery might play a role in this process. To do this 
we made use of the Pseudovirion (PsVs) system, where L1 and L2 are assembled into PsVs in HEK293TT cells 
and package a luciferase reporter plasmid35. In this study we used HPV-16, HPV-5, BPV-1, MmuPV-1 and SfPV-
1, and as a control we also included Merkel Cell Polyomavirus (MCPyV) in the assays, which in our previous 
assays was found to be unaffected by TSG101 depletion30. HaCaT cells were first transfected with siRNAs against 
TSG101, VPS4A, VPS4B and HRS and after 72 h the cells were infected with the different PsVs containing lucif-
erase. After a further 48 hrs the cells were harvested and luciferase activity monitored. The results are shown 
in Fig. 1 and again show an important role for TSG101 in infection with HPV-16 and BPV-1 PsVs, which is in 
agreement with previous reports30. Interestingly, we also find a requirement for TSG101 in infection with multiple 
other PV types, including cutaneous HPV-5 and also the animal-derived MmuPV-1 and SfPV-1. Analysis of the 
other ESCRT components shows a striking requirement for both VPS4A and VPS4B, which again is conserved 
across all the PVs analyses. Again, loss of either of these proteins has no effect on infection with MCPyV. Finally, 
HRS depletion appears to have no effect upon infection with the different PV PsVs, but intriguingly does appear 
to promote uptake of MCPyV. Taken together these studies define a subset of ESCRT-related components as being 
required for infection with multiple PV types.
Both VPS4A and VPS4B interact with HPV-16 L1 and L2. Considering the importance of VPS4A and 
VPS4B for efficient infectious entry with multiple PV types, we were next interested in ascertaining whether there 
was any potential for interaction between these two proteins and the HPV capsid proteins. To do this we first 
performed a simple GST pull-down assay where HPV-16 L1 and L2 were expressed as GST fusion proteins and 
used in pull-down assays on cell extracts derived from cells over-expressing VPS4A, VPS4B and HRS. The results 
obtained in Fig. 2A demonstrate a clear ability of both L1 and L2 to interact with VPS4A and VPS4B, but no inter-
action was seen with HRS. In order to gain insight into the relative robustness of this interaction the assay was 
repeated with VPS4B, but the pull-downs were washed in progressively increasing concentrations of detergent. 
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As can be seen from Fig. 2B the interactions between HPV-16 L1 and HPV-16 L2 with VPS4B are resistant to 2% 
Triton X-100, indicating a robust association.
To determine whether the interaction between the virion components and VPS4B was direct and involved 
its N-terminal MIT (microtubule interacting and trafficking) protein binding domain38, we performed a series 
of direct interaction assays using purified wild type VPS4B and a mutant VPS4B where the MIT domain was 
deleted, together with purified HPV-16 GST.L1 and GST.L2 fusion proteins. The results obtained are shown in 
Fig. 2C and demonstrate a clear direct interaction between HPV-16 L2 and VPS4B, whilst association between 
VPS4B and HPV-16 L1 was much weaker, albeit still detectable. Interestingly, both HPV-16 L1 and L2 failed to 
interact with the mutant VPS4B where the MIT domain was deleted.
We were next interested in determining whether we could detect interaction between endogenous VPS4B 
and the components of the viral capsid during a viral infection. To do this we infected HaCaT cells with HPV-16 
PsVs and harvested the cells at 3 h, 6 h and 9 h post infection in order to determine when the interactions might 
take place. The extracts were then immunoprecipitated using anti-VPS4B antibody or with anti-Flag antibody as 
a control. The immunoprecipitates were then analysed for the presence of L1 and L2 by western blotting. As can 
be seen from Fig. 3, there is a clear co-immunoprecipitation of VPS4B and HPV-16 L1 at the 3 h and 6 h time 
points post-infection. However by 9 h post-infection the interaction appears to have been lost, suggesting that the 
interaction between L1 and VPS4B occurs relatively early during the infectious entry of HPV-16 PsVs. It is also 
noteworthy that under these particular experimental conditions, we were unable to detect interaction between 
L2 and VPS4B.
HPV-16 infectious entry requires catalytically active VPS4. VPS4 proteins play critical roles in recy-
cling components of the ESCRT machinery from the membranes of the MVBs for further rounds of vesicle for-
mation33,34. This requires the VPS4 AAA-ATPase activity, defects in which give rise to large aberrant membrane 
structures41. We were therefore interested in determining whether the catalytic activity of VPS4 was likewise also 
required for HPV-16 infection. To investigate this we made use of previously described HEK293 cells containing 
an ecdysone receptor-inducible wild type VPS4 and a catalytically inactive VPS436. This mutant has a single E/Q 
substitution in the ATPase active site (VPS4EQ) and generates a dominant negative form of VPS4. The wild type 
and mutant VPS4EQ were induced with ponA for 24 h and the cells were then infected with HPV-16, BPV-1 
Figure 1. Loss of ESCRT components TSG101 and VPS4 inhibits papillomavirus infection. Panel A. HaCaT 
cells were transfected with siRNAs against TSG101, VPS4A, VPS4B, HRS or scrambled siRNA (siCTRL) as a 
control. After 72 h the cells were infected with different PsVs: HPV-16, HPV-5, BPV-1, SfPV-1, MmuPV-1, all 
carrying a luciferase reporter plasmid. Merkel cell polyomavirus (MCPyV) was used for comparison. After 
48 h the cells were harvested and the level of luciferase activity was measured in triplicate by luminometry. 
The values were corrected for background luminescence and normalized to siCTRL transfected cells infected 
with the same type of pseudovirus. Results are expressed as means with the standard deviations of at least 
three independent experiments. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. Panel B. Western blot showing the levels 
of TSG101, VPS4A, VPS4B and HRS in HaCaT cells following transfection with the different siRNAs. Alpha-
actinin was used as a loading control.
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and MCPyV PsVs containing a luciferase reporter plasmid. After a further 24 h the cells were harvested and 
luciferase activity monitored. The results in Fig. 4 show that induction of the wild type VPS4 has minimal effect 
upon virus infection, however induction of the catalytically inactive dominant negative mutant form of VPS4 
exerts a dramatic inhibitory effect upon infection with HPV-16 and BPV-1 PsVs. In agreement with the siRNA 
experiments, the dominant negative VPS4EQ mutant has no deleterious effect upon infection with MCPyV. These 
results demonstrate that infection with HPV-16 and BPV-1 PsVs requires the catalytic activity of VPS4, and indi-
cates that perturbing MVB formation inhibits HPV infectious entry.
Inactivation of VPS4 blocks capsid disassembly. Having shown that VPS4 ATPase activity plays an 
important role in the HPV-16 infectious entry pathway, we were next interested in ascertaining where the defects 
in HPV-16 entry might be in the cells expressing the mutant VPS4. To do this we first monitored the pattern of 
PsVs uptake by performing immunofluoresence for total HPV-16 L1 7 h post-infection in HEK293 cells in which 
the VPS4 wild type or VPS4EQ mutant were induced. The results obtained are shown in Fig. 5 and demonstrate 
an apparently similar distribution of HPV-16 L1 positive PsVs in the presence and absence of the wild type and 
mutant VPS4. Noteworthy however, is the accumulation of mutant VPS4 in larger vesicular-like structures, in 
agreement with previous studies36, where there is also a degree of L1 accumulation.
We then proceeded to investigate whether the endocytosed PsVs exhibited any defects in capsid disassembly 
in cells expressing the dominant negative mutant of VPS4. The VPS4 inducible HEK293 cells were again infected 
with HPV-16 PsVs and 7 h post infection the cells were fixed and immunofluorescence analysis performed using 
the 33L1-7 antibody which recognizes an epitope on L1 that is a marker of capsid disassembly13,42. The results 
in Fig. 6 show that capsid disassembly, indicated by 33L1-7 reactivity, occurs to a similar degree in cells that are 
uninduced and in cells that are expressing the wild type VPS4. In contrast, in cells expressing the VPS4EQ cata-
lytically inactive mutant, there is a dramatic decrease in the number of cells positive for the 33L1-7 epitope. These 
results indicate that in the absence of functional VPS4 there is a marked defect in HPV-16 capsid disassembly.
Figure 2. The ESCRT component VPS4 interacts with HPV-16 L1 and L2. Panel A. HEK293 cells were 
transfected with VPS4AGFP, VPS4BDsRED or HRSGFP expressing plasmids. 24 h after transfection the cells 
were lysed and extracts incubated with purified GSTHPV-16L1, GSTHPV-16L2 or GST alone as a control, 
for 2 h at room temperature. After extensive washing the bound protein were analyzed by Western blotting 
against VPS4A, VPS4B and HRS (upper panel). The lower panel shows the Ponceau stain of the nitrocellulose 
membrane. Panel B. HEK293 cells were transfected with VPS4BDsRED, and after 24 h the cells were lysed and 
extracts incubated with GSTHPV-16L1, GSTHPV-16L2 or GST alone as a control. The beads were then washed 
with different concentrations of Triton-X-100 (0, 5%, 1%, 2%) in PBS and bound proteins were analyzed by 
western blotting using anti VPS4B antibody. Panel C. The HPV-16 L1 and L2 GST fusion proteins were purified 
and used in interaction assays with purified His-tagged VPS4B wild type (WT) and VPS4B delta MIT mutant 
(Mut) proteins. After extensive washing bound VPS4 was detected by western blotting and the results shown in 
the upper panel. The left two lanes show the VPS4 protein inputs. The lower panel shows the Coomassie stain of 
the fusion proteins used in the binding assays.
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Although the immunofluorescence analyses indicate no major defects in virus entry in the VPS4 
mutant-expressing cells, we wanted to further address this by monitoring the levels of L1 and L2 expression 24 h 
post-infection. To do this the VPS4 inducible cells were infected with HPV-16 PsVs and after 1 h the cells were 
Figure 3. VPS4B interacts with HPV-16 L1 during viral infection. HaCaT cells were infected with HPV-
16 PsVs for 1 h at 4 °C. Cells were then washed with PBS and incubated at 37 °C. At 3 h, 6 h, 9 h post-infection 
the cells were harvested and cell extracts incubated with anti-VPS4B or rabbit anti-Flag antibody (control) 
overnight at 4 °C. The immunoprecipitates were then incubated with protein A conjugated sepharose beads 
for 1 h at room temperature. Any co-immunoprecipitating L1 and L2 proteins were then detected by western 
blotting using anti-L1 and anti-L2 antibodies (top panel). The lower panel shows the protein inputs for VPS4B, 
L1 and L2.
Figure 4. Expression of catalytically inactive VPS4EQ-GFP cells blocks infection with HPV-16 and BPV-1.  
Ecdysone responsive HEK 293 cells were incubated either without or with 1 μ M ponA to induce expression 
of the VPS4WT-GFP and VPS4EQ-GFP proteins. After 24 h, the cells were infected with HPV-16, BPV-1 or 
MCPyV PsVs carrying a luciferase reporter plasmid. After 24 h the cells were harvested and luciferase activity 
assayed in triplicate by luminometry. The graphs are from at least three independent experiments and the means 
with standard deviations are shown. Panel B. Western blot analysis showing the expression of the VPS4WT-GFP 
and VPS4EQ-GFP proteins 24 h − /+ induction with 1 μ M ponA. Alpha-actinin was used as loading control.
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treated with trypsin to remove any non-internalised virus and harvested. The remaining cells were then left for 
24 h and after a further round of trypsin treatment the cells were harvested and the levels of L1 and L2 protein 
remaining within the cells, were monitored by western blotting. The results in Fig. 7 show that L1 and L2 are still 
Figure 5. HPV-16 L1 colocalizes with the VPS4WT-GFP and VPS4EQ-GFP proteins. 293-VPS4WT-GFP 
and 293-VPS4EQ-GFP cells were either untreated (− ) or induced (+ ) with 1 μ M ponA and after 24 h were then 
infected with HPV-16 PsVs. 7 h postinfection the cells were fixed and stained for total HPV-16 L1 protein using 
mouse anti-L1 antibody (red). The induced VPS4WT-GFP and VPS4EQ-GFP proteins can be seen in green. 
Representative pictures are shown in panel A. Quantification of total L1 staining is shown in panel B.
Figure 6. HPV-16 capsid disassembly is inhibited in cells expressing catalytically inactive VPS4EQ. 
293-VPS4WT-GFP and 293-VPS4EQ-GFP cells were either untreated (− ) or induced (+ ) with 1 μ M ponA and 
after 24 h were infected with HPV-16 PsVs. 7 h postinfection the cells were fixed and stained using the 33L1-7 
monoclonal antibody (red). The induced VPS4WT-GFP and VPS4EQ-GFP proteins can be seen in green. 
Representative pictures are shown in panel A. Quantification of virus disassembly based on the 33L1-7 staining 
is shown in panel B.
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very readily detectable in the VPS4EQ mutant expressing cells at this late time-point post-infection. In contrast, 
the levels of L1 and L2 are reduced in the wild type VPS4 expressing cells. These results appear to indicate no 
major defect in the entry of HPV-16 PsVs into the VPS4EQ mutant expressing cells. Rather, they suggest that 
entry is either more efficient than in the wild type VPS4-expressing cells, or more likely, that the processing of L1 
and L2 in the mutant VPS4EQ-expressing cells is in some way perturbed, resulting in the maintenance of higher 
levels of L1 and L2.
HPV-16 L1 and L2 form a complex with VPS4 in vivo. Having found evidence in Fig. 3 that HPV-16 
L1 could interact with VPS4 during the course of infectious entry, we also wanted to determine whether this 
also occurred with the VPS4EQ mutant. Again we used the VPS4 inducible HEK293 cells and infected them 
with HPV-16 PsVs. The cells were harvested at 6 h and 9 h post-infection and immunoprecipitated with rabbit 
anti-GFP antibody to immunoprecipitate the GFP-tagged VPS4 protein. Co-immunoprecipitating L1 and L2 
was then detected by western blotting and the results obtained are shown in Fig. 8. In agreement with the results 
in Fig. 3, L1 co-immunoprecipitates with VPS4 at the 6 h time point post-infection, but this is not visible 9 h 
post-infection, again suggesting an interaction occurring early in infection. Interestingly, there appears to be a 
somewhat stronger association between L1 and the mutant VPS4EQ than with the wild type protein, although 
this needs to be tempered by the fact that there is somewhat more mutant VPS4 present than the wild type in this 
experiment. In addition, this analysis shows clear evidence of association between HPV-16 L2 and the wild type 
and mutant forms of the VPS4 protein. Taken together these results demonstrate that incoming HPV-16 PsVs 
complex with VPS4, and that this complex requires catalytically active VPS4 protein to ensure the completion of 
successful virus entry and capsid disassembly.
Discussion
In this study we have investigated how the ESCRT machinery contributes towards HPV infection. We provide 
evidence of an important role for this complex in infection with multiple PV types, suggesting that this plays 
an evolutionarily conserved role in PV infectious entry. Furthermore, we provide evidence for a critical role for 
the VPS4 component of the ESCRT machinery, since loss of its expression or inactivation of its ATPase activity 
through the generation of a dominant negative mutation results in a dramatic reduction in infection with HPV-16 
PsVs. The defect appears to be at an early step in infection, and corresponds to a stage prior to capsid disassembly. 
At this stage we cannot say whether the effects of knock down of VPS4 on virus infection are indirect due to a gen-
eral perturbation of the endocytic machinery, or whether there is a more specific role in HPV entry. Intriguingly 
however, both L1 and L2 appear to be capable of independent direct association with VPS4, and can be found in 
complex with VPS4 at early times post-infection. These results suggest that VPS4 performs a function that favours 
capsid disassembly and allows a continuation of the later stages of infectious entry.
Recent studies have provided some compelling insights into a potential role for the ESCRT machinery and 
MVB formation in HPV infectious entry. This was initially triggered by studies showing the presence of incoming 
Figure 7. HPV-16 L1 and L2 appear more stable in mutant VPS4EQ expressing cells. The 293-VPS4WT-
GFP and 293-VPS4EQ-GFP cells were induced with 1 μ M ponA and after 24 h were infected with HPV-16 PsVs 
for 1 h at 4 °C. Cells were then washed and incubated at 37 °C for 24 h. The cells were harvested at the different 
times and L1 and L2 levels analysed by western blotting. The extracts are as follows: the zero time-points 
corresponds to the total cell lysate collected after 1 h infection (total input virus) or the lysate from cells which 
were first treated for 15 minutes with trypsin after 1 h infection (to detect internalized virus); the cells harvested 
at 24 h were also treated with trypsin 15 mins prior to harvest to remove any residual non-internalized virus 
and therefore represent the residual internalized L1 and L2. Alpha-actinin was used as a loading control and the 
induced VPS4 proteins were detected using western blotting against GFP. Note the apparent increase in L1 and 
L2 levels in the mutant VPS4EQ expressing cells.
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virions in endosomes containing MVBs12, and a requirement for TSG101 for efficient infectious entry30. More 
recently, the ESCRT accessory protein ALIX was also shown to play an import role in viral trafficking and capsid 
disassembly31. In the present study we found an important role for ESCRT accessory protein VPS4 for infection 
with HPV-16 PsVs. In addition, whilst previous studies had shown that TSG101 was also required for infection 
with BPV-1 PsVs30 here we show an important role for both TSG101 and VPS4 for infection with cutaneous 
HPV-5 PsVs and also mouse MmuPV-1 and rabbit SfPV-1 indicating that the ESCRT machinery most likely plays 
a role in infection with multiple PV types, and demonstrates an evolutionarily conserved step in the infectious 
entry of multiple PV types.
Identifying the two VPS4 isoforms, VPS4A and VPS4B AAA-ATPase proteins, as important elements in 
HPV infection is particularly exciting. These proteins play critical roles in separating components of the ESCRT 
machinery from the MVBs that form within late endosomes. Both proteins form heteromeric complexes and 
defects in either results in aberrant membrane E compartments43. Whilst we have not attempted to differentiate 
between these two isoforms as to whether they exert different functions during virus infection however, based 
on the similarity of effects in the siRNA knock down assays, it seems likely that their respective functions will be 
similar. An essential requirement for VPS4 activity is a functional ATPase. By using a cell line which expresses a 
dominant negative mutation within the ATPase active site, we find that the VPS4 ATPase activity is also essential 
for HPV-16 PsVs infection. Interestingly, cells expressing this mutant display major defects in MVB maturation38, 
and currently it is unclear whether the defect in infection is simply a side-effect of an alteration in MVB formation 
and endosomal maturation. However, it is tempting to suggest that the effects of VPS4 are rather more direct, and 
there is some compelling evidence to support this. First, we find clear evidence for direct interaction of the L1 and 
L2 capsid proteins with VPS4 in vitro, suggesting that both L1 and L2, might be bound by VPS4. This interaction 
requires an intact MIT domain, but currently we have found no evidence for the presence of a classical MIT 
interaction motif44,45 in either L1 or L2. Therefore further studies will be required to characterize the mechanism 
of interaction and to also determine whether L1 or L2 can affect the ability of VPS4 to interact with its cellular 
binding partners.
There is also clear evidence of interaction of L1 and L2 with VPS4 during HPV-16 PsVs infectious entry. 
Most interestingly, this interaction appears to occur at relatively early time points post-infection, with interaction 
between L1 and VPS4 detectable at 3 h and 6 h post-infection but by 9 h post infection the interaction was not 
detectable. The lack of interaction at later time points would suggest that incoming virions pass through this point 
in the entry pathway relatively early during infection, and this is in agreement with previous studies which have 
shown that virion trafficking can be rapid46.
Although we could only see evidence of L1 interacting with endogenous VPS4 in HaCaT cells, both L1 and 
L2 were found in complex with VPS4 in the HEK293 cells expressing GFP-tagged forms of the wild type and 
catalytically inactive forms of VPS4. The reason for this difference is unclear, but might be a reflection either of 
the very high levels of infection obtained in HEK293 cells or the higher levels of VPS4 expression in the inducible 
cell lines. Further studies will be needed to ascertain whether L1 and L2 are associated with VPS4 as part of a 
complex, and what specific role this may play in the infection process.
Figure 8. Both HPV16 L1 and HPV16 L2 interact with VPS4WT-GFP and VPS4EQ-GFP during virus 
infection. The 293-VPS4WT-GFP and 293-VPS4EQ-GFP cells were either untreated (− ) or induced (+ )  
with 1 μ M ponA and after 24 h were infected with HPV-16 PsVs. At 6 h and 9 h post infection the cells 
were harvested and cell extracts incubated with rabbit anti-GFP antibody overnight at 4 °C. The next day 
immunoprecipitates were collected on protein A conjugated sepharose beads for 1 h at room temperature. The 
co-immunoprecipitating L1 and L2 proteins were then detected by western blotting using mouse anti-L1 and 
mouse anti-L2 antibodies (top panel). The lower panel shows the inputs for HPV16 L1, HPV16 L2 and VPS4 
(GFP).
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Having found an essential role for VPS4 in efficient infectious entry, we were next interested in determining 
where the interaction was required. Clearly interaction occurs quite early. Analysis of virus uptake by immuno-
fluorescence or trypsin digestion of cell surface-bound virions seems to indicate that uptake of the virus is not 
affected by loss of VPS4 ATPase activity. However there does seem to be accumulation of incoming PsVs in the 
aberrant membrane structures that form within cells with defective VPS4, and this appears to be accompanied by 
an increase in the stability of the incoming L1 and L2 proteins, suggesting a block in the endocytic processing of 
these two viral proteins. Most intriguingly we see that the defect in infection caused by expression of the VPS4EQ 
mutant appears to occur at an early stage prior to capsid disassembly. Using the 33L1-7 antibody as a marker of 
capsid disassembly, we see clear evidence of a dramatic decrease in the ability to detect capsid disassembly in cells 
that are expressing the catalytically inactive mutant form of VPS4. This suggests that the VPS4 ATPase activity is 
required for capsid disassembly and subsequent trafficking of L1 to the lysosomal compartments. It is interesting 
to note that previous studies had shown a requirement for cyclophilins in the separation of L1 from L213, a step in 
infectious entry that was also blocked by using broad-spectrum ATPase inhibitors47. Therefore it is possible that 
VPS4 is also playing a role in ensuring the proper separation of L1 from L2 during virus infection.
Many other viruses have been shown to utilize components of the ESCRT machinery for various aspects of 
their life cycles48, but in the majority of cases this involves events related to membrane fusion or fission with 
enveloped viruses. Obviously the role of the ESCRT machinery in non-enveloped virus infection is very different. 
The studies presented here and elsewhere31 suggest that MVB formation is an important step in HPV infectious 
entry. Furthermore, we provide evidence that this plays an important role during the early stages of infection, 
prior to capsid disassembly. Finally, we propose that the ATPase activity of VPS4 might be playing a role in ensur-
ing efficient partitioning of L1 from L2, and thereby promoting successful capsid disassembly. Taken together this 
suggests that there may be two distinct roles for the ESCRT machinery, one involving endosome maturation and 
the other potentially in aiding capsid uncoating.
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